Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
2018 ◽
Vol 5
(9)
◽
pp. e403-e410
◽
Keyword(s):
Phase 2
◽